SFU
AMGN icon

Stonehage Fleming (UK)’s Amgen AMGN Stock Holding History

Stonehage Fleming (UK)’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-14,149
Closed -$2.26M – 188
2015
Q1 		$2.26M Buy
14,149
+3,100
+28% +$488K 1.05% 17
2014
Q4 		$1.76M Sell
11,049
-4,000
-27% -$623K 0.87% 59
2014
Q3 		$2.11M Sell
15,049
-5,300
-26% -$692K 0.94% 26
2014
Q2 		$2.41M Sell
20,349
-5,800
-22% -$671K 0.97% 32
2014
Q1 		$3.23M Buy
26,149
+7,100
+37% +$861K 1.36% 20
2013
Q4 		$2.17M Buy
+19,049
New +$2.17M 0.88% 41

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stonehage Fleming (UK)'s AMGN Position: Q2 2015 in Review

Stonehage Fleming (UK) sold out of Amgen (AMGN) in Q2 2015, closing a stake of 14,149 shares — an estimated $2.26M sold.

Stonehage Fleming (UK) first reported a position in AMGN in Q4 2013 and held it in 6 quarters. The position peaked at $3.23M in Q1 2014. 1,367 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

  • Stonehage Fleming (UK) reported no remaining Amgen position as of Q2 2015 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 14,149 Amgen shares in Q2 2015, an estimated $2.26M.
  • Stonehage Fleming (UK) first reported a position in Amgen in Q4 2013 and held it in 6 quarters.
  • Stonehage Fleming (UK)'s Amgen position peaked at $3.23M in Q1 2014.
  • 1,367 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q2 2015, filed 11 Oct 2019.